Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
| Image |  |
|---|---|
| Description | scientific article published on 22 September 2021 |
| Author/s |
author: Jim Canet Alain Monnereau Gabriel Etienne Xavier Troussard Pascale Cony-Makhoul Edouard Cornet |
| Publication date | September 22, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |